LDL particle size and number compared with LDL cholesterol and risk categorization in end-stage renal disease patients

J Nephrol. 2011 Nov-Dec;24(6):771-7. doi: 10.5301/JN.2011.6376.

Abstract

Background: Few studies have been conducted that make comparisons between traditional measures of cholesterol and cholesterol subfractions, and only one study has compared low-density lipoprotein cholesterol (LDL-C) particle number, LDL-C particle size and LDL-C among end-stage renal disease (ESRD) patients. The purpose of this study was to examine the relationships between cholesterol measures and differences in risk stratification when using ATP-III guidelines compared with cholesterol particle number and size in ESRD patients.

Methods: ESRD patients (n=1,092) from clinics associated with the Central Texas Nephrology Associates were recruited to participate in this study.

Results: LDL particle size categorized more patients at-risk when compared with LDL-C, non-HDL-C and triglycerides. Pearson correlation coefficients revealed a strong significant correlation between LDL-C and LDL particle number (r2=0.908, p=0.0001) and a significant correlation between LDL particle number and LDL particle size (r2=-0.290, p=0.0001). A significant but weak correlation existed between LDL-C and LDL particle size (r2=0.107, p=0.0001). A significant correlation existed between LDL particle number and triglycerides (r2=0.335, p=0.0001) and a significant inverse relationship between LDL particle size and triglycerides (r2=-0.500, p=0.0001).

Conclusions: Our study seems to suggest that using LDL particle size may help to identify those who would not be considered at-risk using LDL-C, non-HDL-C or triglycerides alone, and can be used as a further screening measure that may be more predictive of coronary heart disease outcomes.

Publication types

  • Comparative Study
  • Research Support, N.I.H., Extramural

MeSH terms

  • Aged
  • Cholesterol, HDL / blood
  • Cholesterol, LDL / blood*
  • Coronary Disease / epidemiology*
  • Female
  • Humans
  • Kidney Failure, Chronic / blood*
  • Kidney Failure, Chronic / complications*
  • Kidney Failure, Chronic / therapy
  • Lipoproteins, LDL / blood*
  • Male
  • Middle Aged
  • Particle Size*
  • Predictive Value of Tests
  • Renal Dialysis
  • Risk Assessment
  • Risk Factors
  • Triglycerides / blood

Substances

  • Cholesterol, HDL
  • Cholesterol, LDL
  • Lipoproteins, LDL
  • Triglycerides